Quantcast
Tag archive for ‘MRSA infections decrease’
By Guest Author On Saturday, July 18th, 2015
1 Comment

Fight your fear of hospitals: it could save your life

When you see hospitals through the prism of the media, it’s no wonder you view them as little more than germ-infested harbourers of superbugs. Every day, a new headline states, “MRSA SCARE IN HOSPITALS!” or More...

By The Dispatch On Friday, January 9th, 2015
0 Comments

New study highlights Illinois abortion clinics ‘dangerous’ conditions

A new study says Illinois is facing a serious women’s health crisis and the Illinois Department of Public Health is receiving the heat for the crisis. A new report, released by Illinois Right to Life, documents More...

By The Dispatch On Tuesday, August 26th, 2014
0 Comments

Johns Hopkins study: New UV Light Decontamination System effective against MRSA, HIV, C Diff, others

Spectra254, a developer of high-power, easy-to-use, affordable UVC light decontamination systems, has released a recent study by Johns Hopkins Medicine that reports that Spectra254’s Spectra 1000 Series of UV More...

By The Dispatch On Friday, June 20th, 2014
0 Comments

Phase I study for MRSA, VISA drug, Debio 1450 launched

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase More...

By The Dispatch On Friday, May 23rd, 2014
1 Comment

Dalvance receives FDA approval for the treatment of Staph and Strep skin infections

PRESS RELEASE The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. MRSAImage/CDC Dalvance is intended to treat acute bacterial More...

By The Dispatch On Wednesday, April 30th, 2014
2 Comments

WHO releases report on antibiotic resistance

NEWS RELEASE 30 APRIL 2014 | GENEVA – A new report by WHO–its first to look at antimicrobial resistance, including antibiotic resistance, globally–reveals that this serious threat is no longer a prediction More...

By The Dispatch On Thursday, April 17th, 2014
0 Comments

Vancomycin-resistant MRSA superbug found in Brazil

PRESS RELEASE An international research team led by Cesar A. Arias, M.D., Ph.D., at The University of Texas Health Science Center at Houston (UTHealth) has identified a new superbug that caused a bloodstream infection More...

By The Dispatch On Monday, March 31st, 2014
2 Comments

Sivextro, to treat MRSA skin infections, receives recommendation from FDA Anti-Infective Drugs Advisory Committee

PRESS RELEASE Cubist Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) voted to recommend approval of Cubist’s investigational More...

By The Dispatch On Thursday, March 27th, 2014
2 Comments

Healthcare-associated infections: 722,000 infections in 2011 in the US according to CDC data

On any given day, approximately one in 25 U.S. patients has at least one infection contracted during the course of their hospital care, adding up to about 722,000 infections in 2011, according to new data from the More...

By Robert Herriman On Friday, March 14th, 2014
2 Comments

UCLA researchers issue guidelines on the treatment and management of MRSA skin abscesses

It has been more than 10 years since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and doctors are still grappling with how to diagnose, treat and prevent More...

By Robert Herriman On Saturday, March 8th, 2014
1 Comment

Notre Dame researchers discover ‘oxadiazoles’, a new class of antibiotics for MRSA treatment

A new class of antibiotics have been discovered that show promise in treating difficult to treat infections caused by Methicillin Resistant Staphylococcus aureus (MRSA) and other threats to public health. MRSAImage/CDC Researchers More...

By Guest Author On Wednesday, February 19th, 2014
1 Comment

New Use For Antipsychotic Drug Holds Promise for Tuberculosis Cure

The increase in antibiotic resistance is coming at a bad time, as more and more pharmaceutical companies begin downsizing or eliminating their antimicrobial research branches due to lack of profits.  Fearing a More...

By The Dispatch On Monday, December 30th, 2013
0 Comments

FDA accepts Cubist’s NDA for the investigational antibiotic tedizolid to treat MRSA infections

PRESS RELEASE  Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic tedizolid More...

By Robert Herriman On Wednesday, December 4th, 2013
0 Comments

Becton Dickinson receives FDA clearance to market the BD MAX™ StaphSR Assay

Press Release BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced yesterday it has received FDA clearance to market the BD MAX™ StaphSR More...

By Robert Herriman On Thursday, October 17th, 2013
0 Comments

Narrow-spectrum ultraviolet light could dramatically reduce surgical infections from organisms like MRSA: Study

New research suggests that narrow-spectrum ultraviolet (UV) light could dramatically reduce  surgical wound infections such as those caused by MRSA, according to a study by Columbia University Medical Center More...

By Robert Herriman On Saturday, October 12th, 2013
1 Comment

Buccaneers report third player with MRSA, call on DICON to help

In a follow up to a report of two Tampa Bay Buccaneers being infected with Methicillin-resistant Staphylococcus aureus, or more commonly known as MRSA, ESPN is reporting a third Buc contracting the antibiotic-resistant More...

By Robert Herriman On Saturday, September 21st, 2013
2 Comments

Duke advises NFL on use of chlorhexidine gluconate to prevent MRSA

With reports of the antibiotic resistant bacterial strain, Methicillin-resistant Staphylococcus aureus, or more commonly known as MRSA, in high contact sports like football and wrestling, researchers are looking More...

By Robert Herriman On Wednesday, September 18th, 2013
2 Comments

MRSA infections down in all categories, hospital acquired down more than 50% according to study

Infections caused by Methicillin-resistant Staphylococcus aureus, or MRSA, has decreased in all settings, according to new data published in The Journal of the American Medical Association (JAMA), Internal Medicine More...

By Robert Herriman On Saturday, August 24th, 2013
1 Comment

Buccaneers, Carl Nicks and Lawrence Tynes sidelined with MRSA infections, One Buc Place sanitized

Two Tampa Bay Buccaneers have been diagnosed with Methicillin-resistant Staphylococcus aureus, better known as MRSA infections prompting the signing of a new kicker and a thorough sanitizing of One Buc Place. Credits: More...

By Robert Herriman On Thursday, July 18th, 2013
2 Comments

UC San Diego scientists discover ‘anthracimycin’, compound that kills anthrax, MRSA

Researchers from Scripps Institution of Oceanography at UC San Diego have discovered a compound from a microbe from the ocean that shows lethality against such bacterial pathogens as anthrax and MRSA and may set More...


Recent Posts

September 19, 2019, Comments Off on

September 19, 2019, Comments Off on

September 19, 2019, Comments Off on

September 19, 2019, Comments Off on

September 19, 2019, Comments Off on

September 19, 2019, Comments Off on

September 19, 2019, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History